Global NK Cells Market Growth 2020-2025

Publication Month: Dec 2020 | No. of Pages: 162 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the NK Cells market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in NK Cells business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of NK Cells market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the NK Cells, covering the supply chain analysis, impact assessment to the NK Cells market size growth rate in several scenarios, and the measures to be undertaken by NK Cells companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer
Cardiovascular Diseases
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Chipscreen Biosciences
Henry Ford Health Services
Affimed NV
Innate Pharma
Takeda
Altor BioScience
Bristol-Myers Squibb
Sorrento Therapeutics
NKT
NantKwest
Fortress Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global NK Cells consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of NK Cells market by identifying its various subsegments.
Focuses on the key global NK Cells manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the NK Cells with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of NK Cells submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global NK Cells Consumption 2015-2025
2.1.2 NK Cells Consumption CAGR by Region
2.2 NK Cells Segment by Type
2.2.1 Mogamulizumab
2.2.2 Lorvotuzumab Mertansine
2.2.3 Others
2.3 NK Cells Consumption by Type
2.3.1 Global NK Cells Consumption Market Share by Type (2015-2020)
2.3.2 Global NK Cells Revenue and Market Share by Type (2015-2020)
2.3.3 Global NK Cells Sale Price by Type (2015-2020)
2.4 NK Cells Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular Diseases
2.4.3 Others
2.5 NK Cells Consumption by Application
2.5.1 Global NK Cells Consumption Market Share by Type (2015-2020)
2.5.2 Global NK Cells Value and Market Share by Type (2015-2020)
2.5.3 Global NK Cells Sale Price by Type (2015-2020)

3 Global NK Cells by Company
3.1 Global NK Cells Sales Market Share by Company
3.1.1 Global NK Cells Sales by Company (2018-2020)
3.1.2 Global NK Cells Sales Market Share by Company (2018-2020)
3.2 Global NK Cells Revenue Market Share by Company
3.2.1 Global NK Cells Revenue by Company (2018-2020)
3.2.2 Global NK Cells Revenue Market Share by Company (2018-2020)
3.3 Global NK Cells Sale Price by Company
3.4 Global NK Cells Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global NK Cells Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players NK Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NK Cells by Regions
4.1 NK Cells by Regions
4.2 Americas NK Cells Consumption Growth
4.3 APAC NK Cells Consumption Growth
4.4 Europe NK Cells Consumption Growth
4.5 Middle East & Africa NK Cells Consumption Growth

5 Americas
5.1 Americas NK Cells Consumption by Countries
5.1.1 Americas NK Cells Consumption by Countries (2015-2020)
5.1.2 Americas NK Cells Value by Countries (2015-2020)
5.2 Americas NK Cells Consumption by Type
5.3 Americas NK Cells Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC NK Cells Consumption by Regions
6.1.1 APAC NK Cells Consumption by Regions (2015-2020)
6.1.2 APAC NK Cells Value by Regions (2015-2020)
6.2 APAC NK Cells Consumption by Type
6.3 APAC NK Cells Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe NK Cells by Countries
7.1.1 Europe NK Cells Consumption by Countries (2015-2020)
7.1.2 Europe NK Cells Value by Countries (2015-2020)
7.2 Europe NK Cells Consumption by Type
7.3 Europe NK Cells Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa NK Cells by Countries
8.1.1 Middle East & Africa NK Cells Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa NK Cells Value by Countries (2015-2020)
8.2 Middle East & Africa NK Cells Consumption by Type
8.3 Middle East & Africa NK Cells Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 NK Cells Distributors
10.3 NK Cells Customer

11 Global NK Cells Market Forecast
11.1 Global NK Cells Consumption Forecast (2021-2025)
11.2 Global NK Cells Forecast by Regions
11.2.1 Global NK Cells Forecast by Regions (2021-2025)
11.2.2 Global NK Cells Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global NK Cells Forecast by Type
11.8 Global NK Cells Forecast by Application

12 Key Players Analysis
12.1 Chipscreen Biosciences
12.1.1 Company Information
12.1.2 NK Cells Product Offered
12.1.3 Chipscreen Biosciences NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Chipscreen Biosciences Latest Developments
12.2 Henry Ford Health Services
12.2.1 Company Information
12.2.2 NK Cells Product Offered
12.2.3 Henry Ford Health Services NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Henry Ford Health Services Latest Developments
12.3 Affimed NV
12.3.1 Company Information
12.3.2 NK Cells Product Offered
12.3.3 Affimed NV NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Affimed NV Latest Developments
12.4 Innate Pharma
12.4.1 Company Information
12.4.2 NK Cells Product Offered
12.4.3 Innate Pharma NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Innate Pharma Latest Developments
12.5 Takeda
12.5.1 Company Information
12.5.2 NK Cells Product Offered
12.5.3 Takeda NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Takeda Latest Developments
12.6 Altor BioScience
12.6.1 Company Information
12.6.2 NK Cells Product Offered
12.6.3 Altor BioScience NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Altor BioScience Latest Developments
12.7 Bristol-Myers Squibb
12.7.1 Company Information
12.7.2 NK Cells Product Offered
12.7.3 Bristol-Myers Squibb NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Bristol-Myers Squibb Latest Developments
12.8 Sorrento Therapeutics
12.8.1 Company Information
12.8.2 NK Cells Product Offered
12.8.3 Sorrento Therapeutics NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sorrento Therapeutics Latest Developments
12.9 NKT
12.9.1 Company Information
12.9.2 NK Cells Product Offered
12.9.3 NKT NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 NKT Latest Developments
12.10 NantKwest
12.10.1 Company Information
12.10.2 NK Cells Product Offered
12.10.3 NantKwest NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 NantKwest Latest Developments
12.11 Fortress Biotech
12.11.1 Company Information
12.11.2 NK Cells Product Offered
12.11.3 Fortress Biotech NK Cells Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Fortress Biotech Latest Developments

13 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. NK Cells Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Mogamulizumab
Table 5. Major Players of Lorvotuzumab Mertansine
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global NK Cells Consumption Market Share by Type (2015-2020)
Table 9. Global NK Cells Revenue by Type (2015-2020) ($ million)
Table 10. Global NK Cells Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global NK Cells Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global NK Cells Consumption Market Share by Application (2015-2020)
Table 14. Global NK Cells Value by Application (2015-2020)
Table 15. Global NK Cells Value Market Share by Application (2015-2020)
Table 16. Global NK Cells Sale Price by Application (2015-2020)
Table 17. Global NK Cells Sales by Company (2017-2019) (g)
Table 18. Global NK Cells Sales Market Share by Company (2017-2019)
Table 19. Global NK Cells Revenue by Company (2017-2019) ($ Millions)
Table 20. Global NK Cells Revenue Market Share by Company (2017-2019)
Table 21. Global NK Cells Sale Price by Company (2017-2019)
Table 22. Global NK Cells Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players NK Cells Products Offered
Table 24. NK Cells Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global NK Cells Consumption by Regions 2015-2020 (g)
Table 26. Global NK Cells Consumption Market Share by Regions 2015-2020
Table 27. Global NK Cells Value by Regions 2015-2020 ($ Millions)
Table 28. Global NK Cells Value Market Share by Regions 2015-2020
Table 29. Americas NK Cells Consumption by Countries (2015-2020) (g)
Table 30. Americas NK Cells Consumption Market Share by Countries (2015-2020)
Table 31. Americas NK Cells Value by Countries (2015-2020) ($ Millions)
Table 32. Americas NK Cells Value Market Share by Countries (2015-2020)
Table 33. Americas NK Cells Consumption by Type (2015-2020) (g)
Table 34. Americas NK Cells Consumption Market Share by Type (2015-2020)
Table 35. Americas NK Cells Consumption by Application (2015-2020) (g)
Table 36. Americas NK Cells Consumption Market Share by Application (2015-2020)
Table 37. APAC NK Cells Consumption by Regions (2015-2020) (g)
Table 38. APAC NK Cells Consumption Market Share by Regions (2015-2020)
Table 39. APAC NK Cells Value by Regions (2015-2020) ($ Millions)
Table 40. APAC NK Cells Value Market Share by Regions (2015-2020)
Table 41. APAC NK Cells Consumption by Type (2015-2020) (g)
Table 42. APAC NK Cells Consumption Market Share by Type (2015-2020)
Table 43. APAC NK Cells Consumption by Application (2015-2020) (g)
Table 44. APAC NK Cells Consumption Market Share by Application (2015-2020)
Table 45. Europe NK Cells Consumption by Countries (2015-2020) (g)
Table 46. Europe NK Cells Consumption Market Share by Countries (2015-2020)
Table 47. Europe NK Cells Value by Countries (2015-2020) ($ Millions)
Table 48. Europe NK Cells Value Market Share by Countries (2015-2020)
Table 49. Europe NK Cells Consumption by Type (2015-2020) (g)
Table 50. Europe NK Cells Consumption Market Share by Type (2015-2020)
Table 51. Europe NK Cells Consumption by Application (2015-2020) (g)
Table 52. Europe NK Cells Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa NK Cells Consumption by Countries (2015-2020) (g)
Table 54. Middle East & Africa NK Cells Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa NK Cells Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa NK Cells Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa NK Cells Consumption by Type (2015-2020) (g)
Table 58. Middle East & Africa NK Cells Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa NK Cells Consumption by Application (2015-2020) (g)
Table 60. Middle East & Africa NK Cells Consumption Market Share by Application (2015-2020)
Table 61. NK Cells Distributors List
Table 62. NK Cells Customer List
Table 63. Global NK Cells Consumption Forecast by Countries (2021-2025) (g)
Table 64. Global NK Cells Consumption Market Forecast by Regions
Table 65. Global NK Cells Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global NK Cells Value Market Share Forecast by Regions
Table 67. Global NK Cells Consumption Forecast by Type (2021-2025) (g)
Table 68. Global NK Cells Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global NK Cells Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global NK Cells Value Market Share Forecast by Type (2021-2025)
Table 71. Global NK Cells Consumption Forecast by Application (2021-2025) (g)
Table 72. Global NK Cells Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global NK Cells Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global NK Cells Value Market Share Forecast by Application (2021-2025)
Table 75. Chipscreen Biosciences Product Offered
Table 76. Chipscreen Biosciences NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 77. Chipscreen Biosciences Main Business
Table 78. Chipscreen Biosciences Latest Developments
Table 79. Chipscreen Biosciences Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 80. Henry Ford Health Services Product Offered
Table 81. Henry Ford Health Services NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 82. Henry Ford Health Services Main Business
Table 83. Henry Ford Health Services Latest Developments
Table 84. Henry Ford Health Services Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 85. Affimed NV Product Offered
Table 86. Affimed NV NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 87. Affimed NV Main Business
Table 88. Affimed NV Latest Developments
Table 89. Affimed NV Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 90. Innate Pharma Product Offered
Table 91. Innate Pharma NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 92. Innate Pharma Main Business
Table 93. Innate Pharma Latest Developments
Table 94. Innate Pharma Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Product Offered
Table 96. Takeda NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. Takeda Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 100. Altor BioScience Product Offered
Table 101. Altor BioScience NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 102. Altor BioScience Main Business
Table 103. Altor BioScience Latest Developments
Table 104. Altor BioScience Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 105. Bristol-Myers Squibb Product Offered
Table 106. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 107. Bristol-Myers Squibb Main Business
Table 108. Bristol-Myers Squibb Latest Developments
Table 109. Bristol-Myers Squibb NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 110. Sorrento Therapeutics Product Offered
Table 111. Sorrento Therapeutics NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 112. Sorrento Therapeutics Main Business
Table 113. Sorrento Therapeutics Latest Developments
Table 114. Sorrento Therapeutics Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 115. NKT Product Offered
Table 116. NKT NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 117. NKT Main Business
Table 118. NKT Latest Developments
Table 119. NKT Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 120. NantKwest Product Offered
Table 121. NantKwest NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 122. NantKwest Main Business
Table 123. NantKwest Latest Developments
Table 124. NantKwest Basic Information, Company Total Revenue (in $ million), NK Cells Manufacturing Base, Sales Area and Its Competitors
Table 125. Fortress Biotech Product Offered
Table 126. Fortress Biotech NK Cells Sales (g), Revenue ($ Million), Price (USD/g) and Gross Margin (2018-2020E)
Table 127. Fortress Biotech Main Business
Table 128. Fortress Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Fortress Biotech Latest Developments
List of Figures
Figure 1. Picture of NK Cells
Figure 2. NK Cells Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global NK Cells Consumption Growth Rate 2015-2025 (g)
Figure 5. Global NK Cells Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Mogamulizumab
Figure 7. Product Picture of Lorvotuzumab Mertansine
Figure 8. Product Picture of Others
Figure 9. Global NK Cells Consumption Market Share by Type (2015-2020)
Figure 10. Global NK Cells Value Market Share by Type (2015-2020)
Figure 11. NK Cells Consumed in Cancer
Figure 12. Global NK Cells Market: Cancer (2015-2020) (g)
Figure 13. Global NK Cells Market: Cancer (2015-2020) ($ Millions)
Figure 14. NK Cells Consumed in Cardiovascular Diseases
Figure 15. Global NK Cells Market: Cardiovascular Diseases (2015-2020) (g)
Figure 16. Global NK Cells Market: Cardiovascular Diseases (2015-2020) ($ Millions)
Figure 17. NK Cells Consumed in Others
Figure 18. Global NK Cells Market: Others (2015-2020) (g)
Figure 19. Global NK Cells Market: Others (2015-2020) ($ Millions)
Figure 20. Global NK Cells Consumption Market Share by Application (2015-2020)
Figure 21. Global NK Cells Value Market Share by Application (2015-2020)
Figure 22. Global NK Cells Sales Market Share by Company in 2017
Figure 23. Global NK Cells Sales Market Share by Company in 2019
Figure 24. Global NK Cells Revenue Market Share by Company in 2017
Figure 25. Global NK Cells Revenue Market Share by Company in 2019
Figure 26. Global NK Cells Sale Price by Company in 2019
Figure 27. Global NK Cells Consumption Market Share by Regions 2015-2020
Figure 28. Global NK Cells Value Market Share by Regions 2015-2020
Figure 29. Americas NK Cells Consumption 2015-2020 (g)
Figure 30. Americas NK Cells Value 2015-2020 ($ Millions)
Figure 31. APAC NK Cells Consumption 2015-2020 (g)
Figure 32. APAC NK Cells Value 2015-2020 ($ Millions)
Figure 33. Europe NK Cells Consumption 2015-2020 (g)
Figure 34. Europe NK Cells Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa NK Cells Consumption 2015-2020 (g)
Figure 36. Middle East & Africa NK Cells Value 2015-2020 ($ Millions)
Figure 37. Americas NK Cells Consumption Market Share by Countries in 2019
Figure 38. Americas NK Cells Value Market Share by Countries in 2019
Figure 39. Americas NK Cells Consumption Market Share by Type in 2019
Figure 40. Americas NK Cells Consumption Market Share by Application in 2019
Figure 41. United States NK Cells Consumption Growth 2015-2020 (g)
Figure 42. United States NK Cells Value Growth 2015-2020 ($ Millions)
Figure 43. Canada NK Cells Consumption Growth 2015-2020 (g)
Figure 44. Canada NK Cells Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico NK Cells Consumption Growth 2015-2020 (g)
Figure 46. Mexico NK Cells Value Growth 2015-2020 ($ Millions)
Figure 47. APAC NK Cells Consumption Market Share by Countries in 2019
Figure 48. APAC NK Cells Value Market Share by Regions in 2019
Figure 49. APAC NK Cells Consumption Market Share by Type in 2019
Figure 50. APAC NK Cells Consumption Market Share by Application in 2019
Figure 51. China NK Cells Consumption Growth 2015-2020 (g)
Figure 52. China NK Cells Value Growth 2015-2020 ($ Millions)
Figure 53. Japan NK Cells Consumption Growth 2015-2020 (g)
Figure 54. Japan NK Cells Value Growth 2015-2020 ($ Millions)
Figure 55. Korea NK Cells Consumption Growth 2015-2020 (g)
Figure 56. Korea NK Cells Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia NK Cells Consumption Growth 2015-2020 (g)
Figure 58. Southeast Asia NK Cells Value Growth 2015-2020 ($ Millions)
Figure 59. India NK Cells Consumption Growth 2015-2020 (g)
Figure 60. India NK Cells Value Growth 2015-2020 ($ Millions)
Figure 61. Australia NK Cells Consumption Growth 2015-2020 (g)
Figure 62. Australia NK Cells Value Growth 2015-2020 ($ Millions)
Figure 63. Europe NK Cells Consumption Market Share by Countries in 2019
Figure 64. Europe NK Cells Value Market Share by Countries in 2019
Figure 65. Europe NK Cells Consumption Market Share by Type in 2019
Figure 66. Europe NK Cells Consumption Market Share by Application in 2019
Figure 67. Germany NK Cells Consumption Growth 2015-2020 (g)
Figure 68. Germany NK Cells Value Growth 2015-2020 ($ Millions)
Figure 69. France NK Cells Consumption Growth 2015-2020 (g)
Figure 70. France NK Cells Value Growth 2015-2020 ($ Millions)
Figure 71. UK NK Cells Consumption Growth 2015-2020 (g)
Figure 72. UK NK Cells Value Growth 2015-2020 ($ Millions)
Figure 73. Italy NK Cells Consumption Growth 2015-2020 (g)
Figure 74. Italy NK Cells Value Growth 2015-2020 ($ Millions)
Figure 75. Russia NK Cells Consumption Growth 2015-2020 (g)
Figure 76. Russia NK Cells Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa NK Cells Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa NK Cells Value Market Share by Countries in 2019
Figure 79. Middle East & Africa NK Cells Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa NK Cells Consumption Market Share by Application in 2019
Figure 81. Egypt NK Cells Consumption Growth 2015-2020 (g)
Figure 82. Egypt NK Cells Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa NK Cells Consumption Growth 2015-2020 (g)
Figure 84. South Africa NK Cells Value Growth 2015-2020 ($ Millions)
Figure 85. Israel NK Cells Consumption Growth 2015-2020 (g)
Figure 86. Israel NK Cells Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey NK Cells Consumption Growth 2015-2020 (g)
Figure 88. Turkey NK Cells Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries NK Cells Consumption Growth 2015-2020 (g)
Figure 90. GCC Countries NK Cells Value Growth 2015-2020 ($ Millions)
Figure 91. Global NK Cells Consumption Growth Rate Forecast (2021-2025) (g)
Figure 92. Global NK Cells Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas NK Cells Consumption 2021-2025 (g)
Figure 94. Americas NK Cells Value 2021-2025 ($ Millions)
Figure 95. APAC NK Cells Consumption 2021-2025 (g)
Figure 96. APAC NK Cells Value 2021-2025 ($ Millions)
Figure 97. Europe NK Cells Consumption 2021-2025 (g)
Figure 98. Europe NK Cells Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa NK Cells Consumption 2021-2025 (g)
Figure 100. Middle East & Africa NK Cells Value 2021-2025 ($ Millions)
Figure 101. United States NK Cells Consumption 2021-2025 (g)
Figure 102. United States NK Cells Value 2021-2025 ($ Millions)
Figure 103. Canada NK Cells Consumption 2021-2025 (g)
Figure 104. Canada NK Cells Value 2021-2025 ($ Millions)
Figure 105. Mexico NK Cells Consumption 2021-2025 (g)
Figure 106. Mexico NK Cells Value 2021-2025 ($ Millions)
Figure 107. Brazil NK Cells Consumption 2021-2025 (g)
Figure 108. Brazil NK Cells Value 2021-2025 ($ Millions)
Figure 109. China NK Cells Consumption 2021-2025 (g)
Figure 110. China NK Cells Value 2021-2025 ($ Millions)
Figure 111. Japan NK Cells Consumption 2021-2025 (g)
Figure 112. Japan NK Cells Value 2021-2025 ($ Millions)
Figure 113. Korea NK Cells Consumption 2021-2025 (g)
Figure 114. Korea NK Cells Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia NK Cells Consumption 2021-2025 (g)
Figure 116. Southeast Asia NK Cells Value 2021-2025 ($ Millions)
Figure 117. India NK Cells Consumption 2021-2025 (g)
Figure 118. India NK Cells Value 2021-2025 ($ Millions)
Figure 119. Australia NK Cells Consumption 2021-2025 (g)
Figure 120. Australia NK Cells Value 2021-2025 ($ Millions)
Figure 121. Germany NK Cells Consumption 2021-2025 (g)
Figure 122. Germany NK Cells Value 2021-2025 ($ Millions)
Figure 123. France NK Cells Consumption 2021-2025 (g)
Figure 124. France NK Cells Value 2021-2025 ($ Millions)
Figure 125. UK NK Cells Consumption 2021-2025 (g)
Figure 126. UK NK Cells Value 2021-2025 ($ Millions)
Figure 127. Italy NK Cells Consumption 2021-2025 (g)
Figure 128. Italy NK Cells Value 2021-2025 ($ Millions)
Figure 129. Russia NK Cells Consumption 2021-2025 (g)
Figure 130. Russia NK Cells Value 2021-2025 ($ Millions)
Figure 131. Spain NK Cells Consumption 2021-2025 (g)
Figure 132. Spain NK Cells Value 2021-2025 ($ Millions)
Figure 133. Egypt NK Cells Consumption 2021-2025 (g)
Figure 134. Egypt NK Cells Value 2021-2025 ($ Millions)
Figure 135. South Africa NK Cells Consumption 2021-2025 (g)
Figure 136. South Africa NK Cells Value 2021-2025 ($ Millions)
Figure 137. Israel NK Cells Consumption 2021-2025 (g)
Figure 138. Israel NK Cells Value 2021-2025 ($ Millions)
Figure 139. Turkey NK Cells Consumption 2021-2025 (g)
Figure 140. Turkey NK Cells Value 2021-2025 ($ Millions)
Figure 141. GCC Countries NK Cells Consumption 2021-2025 (g)
Figure 142. GCC Countries NK Cells Value 2021-2025 ($ Millions)
Figure 143. Chipscreen Biosciences NK Cells Market Share (2018-2020)
Figure 144. Henry Ford Health Services NK Cells Market Share (2018-2020)
Figure 145. Affimed NV NK Cells Market Share (2018-2020)
Figure 146. Innate Pharma NK Cells Market Share (2018-2020)
Figure 147. Takeda NK Cells Market Share (2018-2020)
Figure 148. Altor BioScience NK Cells Market Share (2018-2020)
Figure 149. Bristol-Myers Squibb NK Cells Market Share (2018-2020)
Figure 150. Sorrento Therapeutics NK Cells Market Share (2018-2020)
Figure 151. NKT NK Cells Market Share (2018-2020)
Figure 152. NantKwest NK Cells Market Share (2018-2020)
Figure 153. Fortress Biotech NK Cells Market Share (2018-2020)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets